Review



deep sequencing approaches  (Illumina Inc)


Bioz Verified Symbol Illumina Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Illumina Inc deep sequencing approaches
    Prevalence of errors at each nucleotide position within the entire viral protein-coding sequence (vCDS) from simplex and duplex reads. The nucleotide sequences were determined by nanopore <t>sequencing</t> using a mixture of three independent amplicons for HIV-1 NL4-3 or HIV-1 JRCSF propagated in cell cultures. The prevalence (%) of all mutations (ALL), substitutions (SUB), insertions (INS) and deletions (DEL) at each position in mixture from three is plotted. The horizontal dotted lines highlight the 15% prevalence threshold.
    Deep Sequencing Approaches, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/deep+sequencing+approach/pmc11130118-16-2-7?v=Illumina+Inc
    Average 90 stars, based on 1 article reviews
    deep sequencing approaches - by Bioz Stars, 2026-08
    90/100 stars

    Images

    1) Product Images from "Population-based nanopore sequencing of the HIV-1 pangenome to identify drug resistance mutations"

    Article Title: Population-based nanopore sequencing of the HIV-1 pangenome to identify drug resistance mutations

    Journal: Scientific Reports

    doi: 10.1038/s41598-024-63054-3

    Prevalence of errors at each nucleotide position within the entire viral protein-coding sequence (vCDS) from simplex and duplex reads. The nucleotide sequences were determined by nanopore sequencing using a mixture of three independent amplicons for HIV-1 NL4-3 or HIV-1 JRCSF propagated in cell cultures. The prevalence (%) of all mutations (ALL), substitutions (SUB), insertions (INS) and deletions (DEL) at each position in mixture from three is plotted. The horizontal dotted lines highlight the 15% prevalence threshold.
    Figure Legend Snippet: Prevalence of errors at each nucleotide position within the entire viral protein-coding sequence (vCDS) from simplex and duplex reads. The nucleotide sequences were determined by nanopore sequencing using a mixture of three independent amplicons for HIV-1 NL4-3 or HIV-1 JRCSF propagated in cell cultures. The prevalence (%) of all mutations (ALL), substitutions (SUB), insertions (INS) and deletions (DEL) at each position in mixture from three is plotted. The horizontal dotted lines highlight the 15% prevalence threshold.

    Techniques Used: Sequencing, Nanopore Sequencing

    Comparisons of nanopore sequencing DR data with archive DR test data obtained by Sanger sequencing. ( A ) Concordance rates (%) of the DR tests between Sanger and nanopore sequencing. The prevalence of detected DR to each drug is displayed with bar graphs. The “Concordant” and “Discordant” columns represent fully matched and inconsistent results between the two sequencing methods. LPV/r: lopinavir boosted with ritonavir, ATV: atazanavir, DRV: darunavir, RTV: ritonavir, ZDV: zidovudine, 3TC: lamivudine, FTC: emtricitabine, ABC: abacavir, TDF: tenofovir, TAF: tenofovir alafenamide, ISL: islatravir, EFV: efavirenz, NVP: nevirapine, ETR: etravirine, RPV: rilpivirine, DOR: doravirine, RAL: raltegravir, EVG: elvitegravir, DTG: dolutegravir, CAB: cabotegravir, BIC: bictegravir, LEN: lenacapavir. ( B ) Concordance rates of coreceptor tropism results based on V3 sequences between the two sequencing methods. The concordance rates of CXR4 (X4) tropism are displayed with a bar graph. Putative tropisms were determined by geno2pheno-C_NGS-Sanger ( https://coreceptor.geno2pheno.org/ ). ( C ) The concordance rates of nucleotide sequences in the pol PR-RT , pol IN, gag capsid, matrix and env c2c5 regions are plotted for each sample with medians and interquartile ranges.
    Figure Legend Snippet: Comparisons of nanopore sequencing DR data with archive DR test data obtained by Sanger sequencing. ( A ) Concordance rates (%) of the DR tests between Sanger and nanopore sequencing. The prevalence of detected DR to each drug is displayed with bar graphs. The “Concordant” and “Discordant” columns represent fully matched and inconsistent results between the two sequencing methods. LPV/r: lopinavir boosted with ritonavir, ATV: atazanavir, DRV: darunavir, RTV: ritonavir, ZDV: zidovudine, 3TC: lamivudine, FTC: emtricitabine, ABC: abacavir, TDF: tenofovir, TAF: tenofovir alafenamide, ISL: islatravir, EFV: efavirenz, NVP: nevirapine, ETR: etravirine, RPV: rilpivirine, DOR: doravirine, RAL: raltegravir, EVG: elvitegravir, DTG: dolutegravir, CAB: cabotegravir, BIC: bictegravir, LEN: lenacapavir. ( B ) Concordance rates of coreceptor tropism results based on V3 sequences between the two sequencing methods. The concordance rates of CXR4 (X4) tropism are displayed with a bar graph. Putative tropisms were determined by geno2pheno-C_NGS-Sanger ( https://coreceptor.geno2pheno.org/ ). ( C ) The concordance rates of nucleotide sequences in the pol PR-RT , pol IN, gag capsid, matrix and env c2c5 regions are plotted for each sample with medians and interquartile ranges.

    Techniques Used: Nanopore Sequencing, Sequencing



    Similar Products

    deep sequencing approach  (Solexa)
    90
    Solexa deep sequencing approach
    Deep Sequencing Approach, supplied by Solexa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/deep+sequencing+approach/10__1016_slash_j__virol__2024__110325-138-21-20?v=Solexa
    Average 90 stars, based on 1 article reviews
    deep sequencing approach - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    deep sequencing approaches based on nanopore  (Oxford Nanopore)
    90
    Oxford Nanopore deep sequencing approaches based on nanopore
    Deep Sequencing Approaches Based On Nanopore, supplied by Oxford Nanopore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/deep+sequencing+approach/pm38987263-59-7-9?v=Oxford+Nanopore
    Average 90 stars, based on 1 article reviews
    deep sequencing approaches based on nanopore - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    deep sequencing approaches  (Illumina Inc)
    90
    Illumina Inc deep sequencing approaches
    Prevalence of errors at each nucleotide position within the entire viral protein-coding sequence (vCDS) from simplex and duplex reads. The nucleotide sequences were determined by nanopore <t>sequencing</t> using a mixture of three independent amplicons for HIV-1 NL4-3 or HIV-1 JRCSF propagated in cell cultures. The prevalence (%) of all mutations (ALL), substitutions (SUB), insertions (INS) and deletions (DEL) at each position in mixture from three is plotted. The horizontal dotted lines highlight the 15% prevalence threshold.
    Deep Sequencing Approaches, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/deep+sequencing+approach/pmc11130118-16-2-7?v=Illumina+Inc
    Average 90 stars, based on 1 article reviews
    deep sequencing approaches - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    deep sequencing approach  (Illumina Inc)
    90
    Illumina Inc deep sequencing approach
    Prevalence of errors at each nucleotide position within the entire viral protein-coding sequence (vCDS) from simplex and duplex reads. The nucleotide sequences were determined by nanopore <t>sequencing</t> using a mixture of three independent amplicons for HIV-1 NL4-3 or HIV-1 JRCSF propagated in cell cultures. The prevalence (%) of all mutations (ALL), substitutions (SUB), insertions (INS) and deletions (DEL) at each position in mixture from three is plotted. The horizontal dotted lines highlight the 15% prevalence threshold.
    Deep Sequencing Approach, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/deep+sequencing+approach/pm38578806-148-7-7?v=Illumina+Inc
    Average 90 stars, based on 1 article reviews
    deep sequencing approach - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    16s and its targeted-gene, deep sequencing approach  (Illumina Inc)
    90
    Illumina Inc 16s and its targeted-gene, deep sequencing approach
    Prevalence of errors at each nucleotide position within the entire viral protein-coding sequence (vCDS) from simplex and duplex reads. The nucleotide sequences were determined by nanopore <t>sequencing</t> using a mixture of three independent amplicons for HIV-1 NL4-3 or HIV-1 JRCSF propagated in cell cultures. The prevalence (%) of all mutations (ALL), substitutions (SUB), insertions (INS) and deletions (DEL) at each position in mixture from three is plotted. The horizontal dotted lines highlight the 15% prevalence threshold.
    16s And Its Targeted Gene, Deep Sequencing Approach, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/deep+sequencing+approach/pmc10678252-5-6-2?v=Illumina+Inc
    Average 90 stars, based on 1 article reviews
    16s and its targeted-gene, deep sequencing approach - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    deep-sequencing approaches  (Tajima Shoji Co Ltd)
    90
    Tajima Shoji Co Ltd deep-sequencing approaches
    Prevalence of errors at each nucleotide position within the entire viral protein-coding sequence (vCDS) from simplex and duplex reads. The nucleotide sequences were determined by nanopore <t>sequencing</t> using a mixture of three independent amplicons for HIV-1 NL4-3 or HIV-1 JRCSF propagated in cell cultures. The prevalence (%) of all mutations (ALL), substitutions (SUB), insertions (INS) and deletions (DEL) at each position in mixture from three is plotted. The horizontal dotted lines highlight the 15% prevalence threshold.
    Deep Sequencing Approaches, supplied by Tajima Shoji Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/deep+sequencing+approach/pmc10324950-486-0-24?v=Tajima+Shoji+Co+Ltd
    Average 90 stars, based on 1 article reviews
    deep-sequencing approaches - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Prevalence of errors at each nucleotide position within the entire viral protein-coding sequence (vCDS) from simplex and duplex reads. The nucleotide sequences were determined by nanopore sequencing using a mixture of three independent amplicons for HIV-1 NL4-3 or HIV-1 JRCSF propagated in cell cultures. The prevalence (%) of all mutations (ALL), substitutions (SUB), insertions (INS) and deletions (DEL) at each position in mixture from three is plotted. The horizontal dotted lines highlight the 15% prevalence threshold.

    Journal: Scientific Reports

    Article Title: Population-based nanopore sequencing of the HIV-1 pangenome to identify drug resistance mutations

    doi: 10.1038/s41598-024-63054-3

    Figure Lengend Snippet: Prevalence of errors at each nucleotide position within the entire viral protein-coding sequence (vCDS) from simplex and duplex reads. The nucleotide sequences were determined by nanopore sequencing using a mixture of three independent amplicons for HIV-1 NL4-3 or HIV-1 JRCSF propagated in cell cultures. The prevalence (%) of all mutations (ALL), substitutions (SUB), insertions (INS) and deletions (DEL) at each position in mixture from three is plotted. The horizontal dotted lines highlight the 15% prevalence threshold.

    Article Snippet: In contrast, deep sequencing approaches based on Illumina or Ion Torrent technologies that have recently been developed for DR testing are able to detect less abundant mutations (~ 1%), although the clinical impact of detecting such low-abundance mutations remains controversial , .

    Techniques: Sequencing, Nanopore Sequencing

    Comparisons of nanopore sequencing DR data with archive DR test data obtained by Sanger sequencing. ( A ) Concordance rates (%) of the DR tests between Sanger and nanopore sequencing. The prevalence of detected DR to each drug is displayed with bar graphs. The “Concordant” and “Discordant” columns represent fully matched and inconsistent results between the two sequencing methods. LPV/r: lopinavir boosted with ritonavir, ATV: atazanavir, DRV: darunavir, RTV: ritonavir, ZDV: zidovudine, 3TC: lamivudine, FTC: emtricitabine, ABC: abacavir, TDF: tenofovir, TAF: tenofovir alafenamide, ISL: islatravir, EFV: efavirenz, NVP: nevirapine, ETR: etravirine, RPV: rilpivirine, DOR: doravirine, RAL: raltegravir, EVG: elvitegravir, DTG: dolutegravir, CAB: cabotegravir, BIC: bictegravir, LEN: lenacapavir. ( B ) Concordance rates of coreceptor tropism results based on V3 sequences between the two sequencing methods. The concordance rates of CXR4 (X4) tropism are displayed with a bar graph. Putative tropisms were determined by geno2pheno-C_NGS-Sanger ( https://coreceptor.geno2pheno.org/ ). ( C ) The concordance rates of nucleotide sequences in the pol PR-RT , pol IN, gag capsid, matrix and env c2c5 regions are plotted for each sample with medians and interquartile ranges.

    Journal: Scientific Reports

    Article Title: Population-based nanopore sequencing of the HIV-1 pangenome to identify drug resistance mutations

    doi: 10.1038/s41598-024-63054-3

    Figure Lengend Snippet: Comparisons of nanopore sequencing DR data with archive DR test data obtained by Sanger sequencing. ( A ) Concordance rates (%) of the DR tests between Sanger and nanopore sequencing. The prevalence of detected DR to each drug is displayed with bar graphs. The “Concordant” and “Discordant” columns represent fully matched and inconsistent results between the two sequencing methods. LPV/r: lopinavir boosted with ritonavir, ATV: atazanavir, DRV: darunavir, RTV: ritonavir, ZDV: zidovudine, 3TC: lamivudine, FTC: emtricitabine, ABC: abacavir, TDF: tenofovir, TAF: tenofovir alafenamide, ISL: islatravir, EFV: efavirenz, NVP: nevirapine, ETR: etravirine, RPV: rilpivirine, DOR: doravirine, RAL: raltegravir, EVG: elvitegravir, DTG: dolutegravir, CAB: cabotegravir, BIC: bictegravir, LEN: lenacapavir. ( B ) Concordance rates of coreceptor tropism results based on V3 sequences between the two sequencing methods. The concordance rates of CXR4 (X4) tropism are displayed with a bar graph. Putative tropisms were determined by geno2pheno-C_NGS-Sanger ( https://coreceptor.geno2pheno.org/ ). ( C ) The concordance rates of nucleotide sequences in the pol PR-RT , pol IN, gag capsid, matrix and env c2c5 regions are plotted for each sample with medians and interquartile ranges.

    Article Snippet: In contrast, deep sequencing approaches based on Illumina or Ion Torrent technologies that have recently been developed for DR testing are able to detect less abundant mutations (~ 1%), although the clinical impact of detecting such low-abundance mutations remains controversial , .

    Techniques: Nanopore Sequencing, Sequencing